Skip to main navigation Skip to search Skip to main content

Piezo1 activation using Yoda1 inhibits macropinocytosis in A431 human epidermoid carcinoma cells

  • Masashi Kuriyama
  • , Hisaaki Hirose
  • , Toshihiro Masuda
  • , Masachika Shudou
  • , Jan Vincent Arafiles
  • , Miki Imanishi
  • , Masashi Maekawa
  • , Yuji Hara
  • , Shiroh Futaki

Research output: Contribution to journal › Article › peer-review

Abstract

Macropinocytosis is a type of endocytosis accompanied by actin rearrangement-driven membrane deformation, such as lamellipodia formation and membrane ruffling, followed by the formation of large vesicles, macropinosomes. Ras-transformed cancer cells efficiently acquire exogenous amino acids for their survival through macropinocytosis. Thus, inhibition of macropinocytosis is a promising strategy for cancer therapy. To date, few specific agents that inhibit macropinocytosis have been developed. Here, focusing on the mechanosensitive ion channel Piezo1, we found that Yoda1, a Piezo1 agonist, potently inhibits macropinocytosis induced by epidermal growth factor (EGF). The inhibition of ruffle formation by Yoda1 was dependent on the extracellular Ca2+ influx through Piezo1 and on the activation of the calcium-activated potassium channel KCa3.1. This suggests that Ca2+ ions can regulate EGF-stimulated macropinocytosis. We propose the potential for macropinocytosis inhibition through the regulation of a mechanosensitive channel activity using chemical tools.

Original languageEnglish
Article number6322
JournalScientific reports
Volume12
Issue number1
DOIs
Publication statusPublished - 2022 Dec

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Piezo1 activation using Yoda1 inhibits macropinocytosis in A431 human epidermoid carcinoma cells'. Together they form a unique fingerprint.

Cite this